$DCPH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Deciphera Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Deciphera Pharmaceuticals, Inc.. Get notifications about new insider transactions in Deciphera Pharmaceuticals, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25 2019 | DCPH | Deciphera Pharmace ... | Flynn Daniel Lee | Chief Scientific Of ... | Buy | M | 3.95 | 24,500 | 96,775 | 24,500 | 0 to 24.5 K |
| Feb 20 2019 | DCPH | Deciphera Pharmace ... | Kelly Thomas Patrick | Chief Financial Off ... | Option Exercise | M | 1.89 | 1,500 | 2,835 | 166,508 | |
| Feb 20 2019 | DCPH | Deciphera Pharmace ... | Kelly Thomas Patrick | Chief Financial Off ... | Sell | S | 30.00 | 1,500 | 45,000 | 0 | 1.5 K to 0 (-100.00 %) |
| Feb 20 2019 | DCPH | Deciphera Pharmace ... | Kelly Thomas Patrick | Chief Financial Off ... | Buy | M | 1.89 | 1,500 | 2,835 | 1,500 | 0 to 1.5 K |
| Feb 19 2019 | DCPH | Deciphera Pharmace ... | Bristol James Arthur | Director | Option Exercise | M | 1.89 | 17,782 | 33,608 | 113,408 | |
| Feb 19 2019 | DCPH | Deciphera Pharmace ... | Bristol James Arthur | Director | Option Exercise | M | 1.89 | 1,101 | 2,081 | 131,190 | |
| Feb 19 2019 | DCPH | Deciphera Pharmace ... | Bristol James Arthur | Director | Sell | S | 28.04 | 17,782 | 498,604 | 0 | 17.8 K to 0 (-100.00 %) |
| Feb 19 2019 | DCPH | Deciphera Pharmace ... | Bristol James Arthur | Director | Buy | M | 1.89 | 17,782 | 33,608 | 17,782 | 0 to 17.8 K |
| Feb 19 2019 | DCPH | Deciphera Pharmace ... | Bristol James Arthur | Director | Sell | S | 28.01 | 1,101 | 30,842 | 0 | 1.1 K to 0 (-100.00 %) |
| Feb 19 2019 | DCPH | Deciphera Pharmace ... | Bristol James Arthur | Director | Buy | M | 1.89 | 1,101 | 2,081 | 1,101 | 0 to 1.1 K |
| Feb 19 2019 | DCPH | Deciphera Pharmace ... | Taylor Michael Douglas | President and CEO | Option Exercise | M | 1.89 | 3,997 | 7,554 | 539,635 | |
| Feb 19 2019 | DCPH | Deciphera Pharmace ... | Taylor Michael Douglas | President and CEO | Option Exercise | M | 1.89 | 4,934 | 9,325 | 543,632 | |
| Feb 19 2019 | DCPH | Deciphera Pharmace ... | Taylor Michael Douglas | President and CEO | Option Exercise | M | 1.89 | 500 | 945 | 548,566 | |
| Feb 19 2019 | DCPH | Deciphera Pharmace ... | Taylor Michael Douglas | President and CEO | Sell | S | 30.00 | 3,997 | 119,913 | 0 | 4 K to 0 (-100.00 %) |
| Feb 19 2019 | DCPH | Deciphera Pharmace ... | Taylor Michael Douglas | President and CEO | Buy | M | 1.89 | 3,997 | 7,554 | 3,997 | 0 to 4 K |
| Feb 19 2019 | DCPH | Deciphera Pharmace ... | Taylor Michael Douglas | President and CEO | Sell | S | 28.01 | 4,934 | 138,193 | 0 | 4.9 K to 0 (-100.00 %) |
| Feb 19 2019 | DCPH | Deciphera Pharmace ... | Taylor Michael Douglas | President and CEO | Buy | M | 1.89 | 4,934 | 9,325 | 4,934 | 0 to 4.9 K |
| Feb 19 2019 | DCPH | Deciphera Pharmace ... | Taylor Michael Douglas | President and CEO | Sell | S | 28.00 | 500 | 14,000 | 0 | 500 to 0 (-100.00 %) |
| Feb 19 2019 | DCPH | Deciphera Pharmace ... | Taylor Michael Douglas | President and CEO | Buy | M | 1.89 | 500 | 945 | 500 | 0 to 500 |
| Feb 07 2019 | DCPH | Deciphera Pharmace ... | Bristol James Arthur | Director | Option Exercise | M | 1.89 | 2,595 | 4,905 | 135,813 | |
| Feb 07 2019 | DCPH | Deciphera Pharmace ... | Bristol James Arthur | Director | Sell | S | 28.02 | 2,595 | 72,704 | 0 | 2.6 K to 0 (-100.00 %) |
| Feb 07 2019 | DCPH | Deciphera Pharmace ... | Bristol James Arthur | Director | Buy | M | 1.89 | 2,595 | 4,905 | 2,595 | 0 to 2.6 K |
| Feb 01 2019 | DCPH | Deciphera Pharmace ... | Taylor Michael Douglas | President and CEO | Option Exercise | A | 26.35 | 263,000 | 6,930,050 | 263,000 | |
| Feb 01 2019 | DCPH | Deciphera Pharmace ... | Ruddy Stephen B. | Chief Technical Off ... | Option Exercise | A | 26.35 | 52,000 | 1,370,200 | 52,000 | |
| Feb 01 2019 | DCPH | Deciphera Pharmace ... | Morl Christopher John | Chief Business Offi ... | Option Exercise | A | 26.35 | 52,000 | 1,370,200 | 52,000 | |
| Feb 01 2019 | DCPH | Deciphera Pharmace ... | Martin Daniel C. | Chief Commercial Of ... | Option Exercise | A | 26.35 | 52,000 | 1,370,200 | 52,000 | |
| Feb 01 2019 | DCPH | Deciphera Pharmace ... | Kelly Thomas Patrick | Chief Financial Off ... | Option Exercise | A | 26.35 | 75,000 | 1,976,250 | 75,000 | |
| Feb 01 2019 | DCPH | Deciphera Pharmace ... | Flynn Daniel Lee | Chief Scientific Of ... | Option Exercise | A | 26.35 | 75,000 | 1,976,250 | 75,000 | |
| Jan 18 2019 | DCPH | Deciphera Pharmace ... | Flynn Daniel Lee | Chief Scientific Of ... | Option Exercise | M | 1.89 | 152,629 | 288,469 | 472,678 | |
| Jan 18 2019 | DCPH | Deciphera Pharmace ... | Flynn Daniel Lee | Chief Scientific Of ... | Sell | S | 26.00 | 152,629 | 3,968,354 | 0 | 152.6 K to 0 (-100.00 %) |
| Jan 18 2019 | DCPH | Deciphera Pharmace ... | Flynn Daniel Lee | Chief Scientific Of ... | Buy | M | 1.89 | 152,629 | 288,469 | 152,629 | 0 to 152.6 K |
| Jan 18 2019 | DCPH | Deciphera Pharmace ... | Flynn Daniel Lee | Chief Scientific Of ... | Gift | G | 0.00 | 91,779 | 0 | 55,270 | 147 K to 55.3 K (-62.41 %) |
| Jan 18 2019 | DCPH | Deciphera Pharmace ... | Flynn Daniel Lee | Chief Scientific Of ... | Gift | G | 0.00 | 91,779 | 0 | 91,779 | 0 to 91.8 K |
| Jan 15 2019 | DCPH | Deciphera Pharmace ... | Flynn Daniel Lee | Chief Scientific Of ... | Option Exercise | M | 1.89 | 300 | 567 | 625,307 | |
| Jan 15 2019 | DCPH | Deciphera Pharmace ... | Flynn Daniel Lee | Chief Scientific Of ... | Sell | S | 26.00 | 300 | 7,800 | 0 | 300 to 0 (-100.00 %) |
| Jan 15 2019 | DCPH | Deciphera Pharmace ... | Flynn Daniel Lee | Chief Scientific Of ... | Buy | M | 1.89 | 300 | 567 | 300 | 0 to 300 |
| Jan 09 2019 | DCPH | Deciphera Pharmace ... | Kelly Thomas Patrick | Chief Financial Off ... | Option Exercise | M | 1.89 | 5,000 | 9,450 | 168,008 | |
| Jan 09 2019 | DCPH | Deciphera Pharmace ... | Kelly Thomas Patrick | Chief Financial Off ... | Sell | S | 25.18 | 5,000 | 125,900 | 0 | 5 K to 0 (-100.00 %) |
| Jan 09 2019 | DCPH | Deciphera Pharmace ... | Kelly Thomas Patrick | Chief Financial Off ... | Buy | M | 1.89 | 5,000 | 9,450 | 5,000 | 0 to 5 K |
| Sep 20 2018 | DCPH | Deciphera Pharmace ... | Rosen Oliver | Chief Medical Offic ... | Option Exercise | A | 29.71 | 68,500 | 2,035,135 | 68,500 | |
| Sep 20 2018 | DCPH | Deciphera Pharmace ... | Rosen Oliver | Chief Medical Offic ... | Option Exercise | M | 6.13 | 45,883 | 281,263 | 45,883 | |
| Sep 20 2018 | DCPH | Deciphera Pharmace ... | Rosen Oliver | Chief Medical Offic ... | Option Exercise | M | 6.13 | 8,121 | 49,782 | 0 | |
| Sep 20 2018 | DCPH | Deciphera Pharmace ... | Rosen Oliver | Chief Medical Offic ... | Option Exercise | M | 3.95 | 48,025 | 189,699 | 48,025 | |
| Sep 20 2018 | DCPH | Deciphera Pharmace ... | Rosen Oliver | Chief Medical Offic ... | Option Exercise | M | 3.95 | 8,500 | 33,575 | 0 | |
| Sep 20 2018 | DCPH | Deciphera Pharmace ... | Rosen Oliver | Chief Medical Offic ... | Option Exercise | M | 1.89 | 46,137 | 87,199 | 46,137 | |
| Sep 20 2018 | DCPH | Deciphera Pharmace ... | Rosen Oliver | Chief Medical Offic ... | Option Exercise | M | 1.89 | 8,166 | 15,434 | 0 | |
| Sep 20 2018 | DCPH | Deciphera Pharmace ... | Rosen Oliver | Chief Medical Offic ... | Option Exercise | M | 1.89 | 207,614 | 392,390 | 207,614 | |
| Sep 20 2018 | DCPH | Deciphera Pharmace ... | Rosen Oliver | Chief Medical Offic ... | Option Exercise | M | 1.89 | 36,746 | 69,450 | 0 | |
| Sep 20 2018 | DCPH | Deciphera Pharmace ... | Flynn Daniel Lee | Chief Scientific Of ... | Option Exercise | A | 29.71 | 68,500 | 2,035,135 | 68,500 | |
| Sep 20 2018 | DCPH | Deciphera Pharmace ... | Flynn Daniel Lee | Chief Scientific Of ... | Option Exercise | M | 6.13 | 151,617 | 929,412 | 151,617 | |
| Sep 20 2018 | DCPH | Deciphera Pharmace ... | Flynn Daniel Lee | Chief Scientific Of ... | Option Exercise | M | 6.13 | 26,835 | 164,499 | 0 | |
| Sep 20 2018 | DCPH | Deciphera Pharmace ... | Flynn Daniel Lee | Chief Scientific Of ... | Option Exercise | M | 3.95 | 39,550 | 156,223 | 39,550 | |
| Sep 20 2018 | DCPH | Deciphera Pharmace ... | Flynn Daniel Lee | Chief Scientific Of ... | Option Exercise | M | 3.95 | 7,000 | 27,650 | 0 | |
| Sep 20 2018 | DCPH | Deciphera Pharmace ... | Flynn Daniel Lee | Chief Scientific Of ... | Option Exercise | M | 1.89 | 139,029 | 262,765 | 139,029 | |
| Sep 20 2018 | DCPH | Deciphera Pharmace ... | Flynn Daniel Lee | Chief Scientific Of ... | Option Exercise | M | 1.89 | 24,607 | 46,507 | 0 | |
| Sep 20 2018 | DCPH | Deciphera Pharmace ... | Flynn Daniel Lee | Chief Scientific Of ... | Option Exercise | M | 1.89 | 625,607 | 1,182,397 | 625,607 | |
| Sep 20 2018 | DCPH | Deciphera Pharmace ... | Flynn Daniel Lee | Chief Scientific Of ... | Option Exercise | M | 1.89 | 110,727 | 209,274 | 0 | |
| Sep 20 2018 | DCPH | Deciphera Pharmace ... | Flynn Daniel Lee | Chief Scientific Of ... | Option Exercise | C | 0.00 | 1,071 | 0 | 0 | |
| Sep 20 2018 | DCPH | Deciphera Pharmace ... | Flynn Daniel Lee | Chief Scientific Of ... | Option Exercise | C | 0.00 | 1,392 | 0 | 0 | |
| Sep 20 2018 | DCPH | Deciphera Pharmace ... | Flynn Daniel Lee | Chief Scientific Of ... | Option Exercise | C | 0.00 | 1,494 | 0 | 0 | |
| Sep 20 2018 | DCPH | Deciphera Pharmace ... | Flynn Daniel Lee | Chief Scientific Of ... | Option Exercise | C | 0.00 | 22,070 | 0 | 0 | |
| Sep 20 2018 | DCPH | Deciphera Pharmace ... | Flynn Daniel Lee | Chief Scientific Of ... | Buy | C | 0.00 | 147,049 | 0 | 147,049 | 0 to 147 K |
| Sep 20 2018 | DCPH | Deciphera Pharmace ... | Morl Christopher John | Chief Business Offi ... | Option Exercise | A | 29.71 | 60,000 | 1,782,600 | 60,000 | |
| Sep 20 2018 | DCPH | Deciphera Pharmace ... | Morl Christopher John | Chief Business Offi ... | Option Exercise | M | 6.13 | 20,283 | 124,335 | 20,283 | |
| Sep 20 2018 | DCPH | Deciphera Pharmace ... | Morl Christopher John | Chief Business Offi ... | Option Exercise | M | 6.13 | 3,590 | 22,007 | 0 | |
| Sep 20 2018 | DCPH | Deciphera Pharmace ... | Morl Christopher John | Chief Business Offi ... | Option Exercise | M | 3.95 | 240,548 | 950,165 | 240,548 | |
| Sep 20 2018 | DCPH | Deciphera Pharmace ... | Morl Christopher John | Chief Business Offi ... | Option Exercise | M | 3.95 | 42,575 | 168,171 | 0 | |
| Sep 20 2018 | DCPH | Deciphera Pharmace ... | Ruddy Stephen B. | Chief Technical Off ... | Option Exercise | A | 26.50 | 90,000 | 2,385,000 | 90,000 | |
| Sep 20 2018 | DCPH | Deciphera Pharmace ... | Martin Daniel C. | Chief Commercial Of ... | Option Exercise | A | 36.10 | 90,000 | 3,249,000 | 90,000 | |
| Sep 20 2018 | DCPH | Deciphera Pharmace ... | Martin Daniel C. | Chief Commercial Of ... | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
| May 21 2018 | DCPH | Deciphera Pharmace ... | Ross Michael Jay | Director | Option Exercise | A | 25.73 | 12,000 | 308,760 | 12,000 | |
| May 21 2018 | DCPH | Deciphera Pharmace ... | Ratcliffe Liam | Director | Option Exercise | A | 25.73 | 12,000 | 308,760 | 12,000 | |
| May 21 2018 | DCPH | Deciphera Pharmace ... | Hoerter Steven L. | Director | Option Exercise | A | 25.73 | 24,000 | 617,520 | 24,000 | |
| May 21 2018 | DCPH | Deciphera Pharmace ... | Allen Patricia L | Director | Option Exercise | A | 25.73 | 12,000 | 308,760 | 12,000 | |
| May 21 2018 | DCPH | Deciphera Pharmace ... | Martin John Richard | Director | Option Exercise | A | 25.73 | 12,000 | 308,760 | 12,000 | |
| May 21 2018 | DCPH | Deciphera Pharmace ... | Bristol James Arthur | Director | Option Exercise | A | 25.73 | 12,000 | 308,760 | 12,000 | |
| May 21 2018 | DCPH | Deciphera Pharmace ... | Benz Edward J. JR | Director | Option Exercise | A | 25.73 | 12,000 | 308,760 | 12,000 | |
| May 21 2018 | DCPH | Deciphera Pharmace ... | Walsh Dennis Leo | Director | Option Exercise | A | 25.73 | 12,000 | 308,760 | 12,000 | |
| Feb 20 2018 | DCPH | Deciphera Pharmace ... | Kelly Thomas Patrick | Chief Financial Off ... | Option Exercise | A | 29.71 | 90,000 | 2,673,900 | 90,000 | |
| Feb 20 2018 | DCPH | Deciphera Pharmace ... | Taylor Michael Douglas | See Remarks | Option Exercise | A | 29.71 | 225,000 | 6,684,750 | 225,000 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | New Leaf Venture Management II ... | 10% Owner | Option Exercise | C | 0.00 | 65,997 | 0 | 0 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | New Leaf Venture Management II ... | 10% Owner | Option Exercise | C | 0.00 | 198,004 | 0 | 0 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | New Leaf Venture Management II ... | 10% Owner | Option Exercise | C | 0.00 | 49,505 | 0 | 0 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | New Leaf Venture Management II ... | 10% Owner | Option Exercise | C | 0.00 | 198,004 | 0 | 0 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | New Leaf Venture Management II ... | 10% Owner | Option Exercise | C | 0.00 | 148,515 | 0 | 0 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | New Leaf Venture Management II ... | 10% Owner | Buy | P | 17.00 | 375,000 | 6,375,000 | 2,146,308 | 1.8 M to 2.1 M (+21.17 %) |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | New Leaf Venture Management II ... | 10% Owner | Buy | C | 0.00 | 372,883 | 0 | 1,771,308 | 1.4 M to 1.8 M (+26.66 %) |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | New Leaf Venture Management II ... | 10% Owner | Buy | C | 0.00 | 1,118,722 | 0 | 1,398,425 | 279.7 K to 1.4 M (+399.97 %) |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | New Leaf Venture Management II ... | 10% Owner | Buy | C | 0.00 | 279,703 | 0 | 279,703 | 0 to 279.7 K |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | New Leaf Venture Management II ... | 10% Owner | Buy | C | 0.00 | 1,118,722 | 0 | 1,957,832 | 839.1 K to 2 M (+133.32 %) |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | New Leaf Venture Management II ... | 10% Owner | Buy | C | 0.00 | 839,110 | 0 | 839,110 | 0 to 839.1 K |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Bristol James Arthur | Director | Option Exercise | M | 6.13 | 67,494 | 413,738 | 67,494 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Bristol James Arthur | Director | Option Exercise | M | 6.13 | 11,946 | 73,229 | 0 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Bristol James Arthur | Director | Option Exercise | M | 3.95 | 50,850 | 200,858 | 50,580 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Bristol James Arthur | Director | Option Exercise | M | 3.95 | 9,000 | 35,550 | 0 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Bristol James Arthur | Director | Option Exercise | M | 1.89 | 30,758 | 58,133 | 30,758 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Bristol James Arthur | Director | Option Exercise | M | 1.89 | 5,444 | 10,289 | 0 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Bristol James Arthur | Director | Option Exercise | M | 1.89 | 138,408 | 261,591 | 138,408 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Bristol James Arthur | Director | Option Exercise | M | 1.89 | 24,497 | 46,299 | 0 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Taylor Michael Douglas | See Remarks | Option Exercise | M | 6.13 | 247,633 | 1,517,990 | 247,633 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Taylor Michael Douglas | See Remarks | Option Exercise | M | 6.13 | 43,829 | 268,672 | 0 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Taylor Michael Douglas | See Remarks | Option Exercise | M | 3.95 | 217,525 | 859,224 | 217,525 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Taylor Michael Douglas | See Remarks | Option Exercise | M | 3.95 | 38,500 | 152,075 | 0 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Taylor Michael Douglas | See Remarks | Option Exercise | M | 1.89 | 553,632 | 1,046,364 | 553,632 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Taylor Michael Douglas | See Remarks | Option Exercise | M | 1.89 | 97,988 | 185,197 | 0 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Taylor Michael Douglas | See Remarks | Option Exercise | M | 1.89 | 123,034 | 232,534 | 123,034 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Taylor Michael Douglas | See Remarks | Option Exercise | M | 1.89 | 21,776 | 41,157 | 0 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Ratcliffe Liam | Director | Option Exercise | C | 0.00 | 65,997 | 0 | 0 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Ratcliffe Liam | Director | Option Exercise | C | 0.00 | 198,004 | 0 | 0 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Ratcliffe Liam | Director | Option Exercise | C | 0.00 | 49,505 | 0 | 0 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Ratcliffe Liam | Director | Option Exercise | C | 0.00 | 198,004 | 0 | 0 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Ratcliffe Liam | Director | Option Exercise | C | 0.00 | 148,515 | 0 | 0 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Ratcliffe Liam | Director | Buy | P | 17.00 | 375,000 | 6,375,000 | 2,146,308 | 1.8 M to 2.1 M (+21.17 %) |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Ratcliffe Liam | Director | Buy | C | 0.00 | 372,883 | 0 | 1,771,308 | 1.4 M to 1.8 M (+26.66 %) |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Ratcliffe Liam | Director | Buy | C | 0.00 | 1,118,722 | 0 | 1,398,425 | 279.7 K to 1.4 M (+399.97 %) |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Ratcliffe Liam | Director | Buy | C | 0.00 | 279,703 | 0 | 279,703 | 0 to 279.7 K |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Ratcliffe Liam | Director | Buy | C | 0.00 | 1,118,722 | 0 | 1,957,832 | 839.1 K to 2 M (+133.32 %) |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Ratcliffe Liam | Director | Buy | C | 0.00 | 839,110 | 0 | 839,110 | 0 to 839.1 K |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Allen Patricia L | Director | Option Exercise | M | 6.13 | 7,181 | 44,020 | 7,181 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Allen Patricia L | Director | Option Exercise | M | 6.13 | 1,271 | 7,791 | 0 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Allen Patricia L | Director | Option Exercise | M | 3.95 | 35,233 | 139,170 | 35,233 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Allen Patricia L | Director | Option Exercise | M | 3.95 | 6,236 | 24,632 | 0 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Benz Edward J. JR | Director | Option Exercise | M | 6.13 | 7,181 | 44,020 | 7,181 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Benz Edward J. JR | Director | Option Exercise | M | 6.13 | 1,271 | 7,791 | 0 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Benz Edward J. JR | Director | Option Exercise | M | 3.95 | 35,233 | 139,170 | 35,233 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Benz Edward J. JR | Director | Option Exercise | M | 3.95 | 6,236 | 24,632 | 0 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Kelly Thomas Patrick | Chief Financial Off ... | Option Exercise | M | 6.13 | 103,219 | 632,732 | 103,219 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Kelly Thomas Patrick | Chief Financial Off ... | Option Exercise | M | 6.13 | 18,269 | 111,989 | 0 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Kelly Thomas Patrick | Chief Financial Off ... | Option Exercise | M | 3.95 | 5,650 | 22,318 | 5,650 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Kelly Thomas Patrick | Chief Financial Off ... | Option Exercise | M | 3.95 | 1,000 | 3,950 | 0 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Kelly Thomas Patrick | Chief Financial Off ... | Option Exercise | M | 1.89 | 38,448 | 72,667 | 38,448 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Kelly Thomas Patrick | Chief Financial Off ... | Option Exercise | M | 1.89 | 6,805 | 12,861 | 0 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Kelly Thomas Patrick | Chief Financial Off ... | Option Exercise | M | 1.89 | 173,008 | 326,985 | 173,008 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Kelly Thomas Patrick | Chief Financial Off ... | Option Exercise | M | 1.89 | 30,621 | 57,874 | 0 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Brightstar Associates LLC | 10% Owner | Option Exercise | C | 0.00 | 263,991 | 0 | 0 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Brightstar Associates LLC | 10% Owner | Option Exercise | C | 0.00 | 396,008 | 0 | 0 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Brightstar Associates LLC | 10% Owner | Option Exercise | C | 0.00 | 297,030 | 0 | 0 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Brightstar Associates LLC | 10% Owner | Option Exercise | C | 0.00 | 1,976,134 | 0 | 0 | |
| Oct 02 2017 | DCPH | Deciphera Pharmace ... | Brightstar Associates LLC | 10% Owner | Buy | C | 0.00 | 16,572,370 | 0 | 16,572,370 | 0 to 16.6 M |